Antion Biosciences ^Company

Antion Biosciences is a Swiss biopharmaceutical company that develops gene and gene-modified cell therapies to treat diseases with unmet medical needs. They have proprietary technologies that allow for the creation of multimodal treatments that aim to enhance clinical safety and efficacy. Antion has products in preclinical development and is committed to creating high-value therapeutic assets while ensuring broad accessibility of their treatments, especially to resource-poor communities. Their patent-protected technologies are versatile, highly effective, and broadly applicable to various therapeutic areas. Antion actively explores collaborations and partnering opportunities to out-license their proprietary technologies and in-license novel technologies that are commercially important to them. The company is founded by a team of leading researchers, entrepreneurs, and financial executives with proven track records in molecular medicine and gene engineering.